EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis

FRA:EWL • US28176E1082

66.18 EUR
+0.66 (+1.01%)
Last: Feb 19, 2026, 07:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EWL. EWL was compared to 67 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making EWL a very profitable company, without any liquidiy or solvency issues. EWL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • EWL had positive earnings in the past year.
  • In the past year EWL had a positive cash flow from operations.
  • EWL had positive earnings in 4 of the past 5 years.
  • Of the past 5 years EWL 4 years had a positive operating cash flow.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • With an excellent Return On Assets value of 10.31%, EWL belongs to the best of the industry, outperforming 88.06% of the companies in the same industry.
  • EWL has a better Return On Equity (13.40%) than 76.12% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.83%, EWL is in the better half of the industry, outperforming 79.10% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for EWL is above the industry average of 9.66%.
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROIC 9.83%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • Looking at the Profit Margin, with a value of 23.25%, EWL belongs to the top of the industry, outperforming 91.04% of the companies in the same industry.
  • In the last couple of years the Profit Margin of EWL has grown nicely.
  • EWL has a Operating Margin of 27.73%. This is amongst the best in the industry. EWL outperforms 95.52% of its industry peers.
  • EWL's Operating Margin has been stable in the last couple of years.
  • EWL's Gross Margin of 78.19% is amongst the best of the industry. EWL outperforms 91.04% of its industry peers.
  • In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
  • EWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • EWL has an Altman-Z score of 11.58. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 11.58, EWL belongs to the top of the industry, outperforming 94.03% of the companies in the same industry.
  • EWL has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
  • EWL's Debt to FCF ratio of 0.75 is amongst the best of the industry. EWL outperforms 89.55% of its industry peers.
  • A Debt/Equity ratio of 0.06 indicates that EWL is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.06, EWL belongs to the best of the industry, outperforming 83.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Altman-Z 11.58
ROIC/WACC0.99
WACC9.98%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • EWL has a Current Ratio of 4.00. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • EWL's Current ratio of 4.00 is amongst the best of the industry. EWL outperforms 91.04% of its industry peers.
  • A Quick Ratio of 3.29 indicates that EWL has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.29, EWL belongs to the top of the industry, outperforming 91.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.29
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

  • The earnings per share for EWL have decreased by -2.29% in the last year.
  • EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.67% yearly.
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.26%

3.2 Future

  • Based on estimates for the next years, EWL will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.79% on average per year.
  • Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 9.72% on average per year.
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue Next Year9.73%
Revenue Next 2Y9.81%
Revenue Next 3Y9.8%
Revenue Next 5Y9.72%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 30.64 indicates a quite expensive valuation of EWL.
  • The rest of the industry has a similar Price/Earnings ratio as EWL.
  • When comparing the Price/Earnings ratio of EWL to the average of the S&P500 Index (27.09), we can say EWL is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 26.37, EWL can be considered very expensive at the moment.
  • 61.19% of the companies in the same industry are cheaper than EWL, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of EWL to the average of the S&P500 Index (27.98), we can say EWL is valued inline with the index average.
Industry RankSector Rank
PE 30.64
Fwd PE 26.37
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • EWL's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. EWL is more expensive than 62.69% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as EWL.
Industry RankSector Rank
P/FCF 56.89
EV/EBITDA 22.72
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EWL does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of EWL may justify a higher PE ratio.
  • A more expensive valuation may be justified as EWL's earnings are expected to grow with 13.01% in the coming years.
PEG (NY)1.9
PEG (5Y)4.59
EPS Next 2Y13.34%
EPS Next 3Y13.01%

0

5. Dividend

5.1 Amount

  • EWL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

EDWARDS LIFESCIENCES CORP

FRA:EWL (2/19/2026, 7:00:00 PM)

66.18

+0.66 (+1.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)04-21
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap38.40B
Revenue(TTM)N/A
Net Income(TTM)1.37B
Analysts79.53
Price Target82.86 (25.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)1.43%
PT rev (3m)7.16%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)-0.06%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)0.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.38%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 30.64
Fwd PE 26.37
P/S 7.73
P/FCF 56.89
P/OCF 44.74
P/B 4.46
P/tB 6.23
EV/EBITDA 22.72
EPS(TTM)2.16
EY3.26%
EPS(NY)2.51
Fwd EY3.79%
FCF(TTM)1.16
FCFY1.76%
OCF(TTM)1.48
OCFY2.24%
SpS8.56
BVpS14.85
TBVpS10.63
PEG (NY)1.9
PEG (5Y)4.59
Graham Number26.86
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROCE 13.97%
ROIC 9.83%
ROICexc 14.65%
ROICexgc 23.24%
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
FCFM 13.59%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Debt/EBITDA 0.33
Cap/Depr 138.79%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 56.86%
Profit Quality 58.45%
Current Ratio 4
Quick Ratio 3.29
Altman-Z 11.58
F-Score6
WACC9.98%
ROIC/WACC0.99
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.26%
Revenue Next Year9.73%
Revenue Next 2Y9.81%
Revenue Next 3Y9.8%
Revenue Next 5Y9.72%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13.12%
EBIT Next 3Y12.54%
EBIT Next 5Y12.98%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%

EDWARDS LIFESCIENCES CORP / EWL.DE FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 6 / 10 to EWL.DE.


What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


What is the profitability of EWL stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 7 / 10.


What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 30.64 and the Price/Book (PB) ratio is 4.46.